Pulz Cristiane, Diniz Rosiane V, Alves Alexandre N F, Tebexreni Antônio S, Carvalho Antônio C, de Paola Angelo A V, Almeida Dirceu R
Department of Medicine, Federal University of São Paulo, São Paulo, Brazil.
Can J Cardiol. 2008 Feb;24(2):131-5. doi: 10.1016/s0828-282x(08)70569-5.
The incremental shuttle test presents some theoretical advantages over the six-minute walk test in chronic heart failure (CHF), including better standardization and less dependency on collaboration.
The present study evaluated test-retest repeatability, test accuracy in predicting a peak oxygen consumption (VO(2)) of 14 mL/kg/min or less, as well as the prognostic value of both walking tests in stable CHF patients.
Sixty-three patients (44 men; New York Heart Association functional class II to IV) underwent an incremental treadmill exercise test and, on another day, the walk test in duplicate.
Patients showed well-preserved functional capacity according to the distance walked in both tests (six-minute walk test 491+/-94 m versus incremental shuttle walk test 422+/-119 m; P<0.001). Interestingly, the six-minute and incremental shuttle walk test differences in distance walked were higher in more disabled patients. The mean bias +/-95% CI of the within-test differences were similar (7+/-40 m and 8+/-45 m, respectively). Peak VO(2), but not distance walked in either test, was associated with survival (P<0.05).
The incremental shuttle walk test showed similar repeatability and accuracy in estimating peak VO(2) compared with the six-minute walk test in CHF patients. Direct measurement of peak VO(2), however, remains superior to either walking test in predicting survival--at least in patients with well-preserved functional capacity.
在慢性心力衰竭(CHF)中,递增式往返试验相较于六分钟步行试验具有一些理论优势,包括更好的标准化以及对协作的依赖性更低。
本研究评估了再测重复性、预测峰值摄氧量(VO₂)≤14 mL/kg/min 的测试准确性,以及这两种步行试验对稳定期 CHF 患者的预后价值。
63 例患者(44 例男性;纽约心脏协会心功能分级 II 至 IV 级)接受了递增式平板运动试验,另一天进行了两次步行试验。
根据两项试验中的步行距离,患者显示出良好的功能能力(六分钟步行试验 491±94 m,递增式往返步行试验 422±119 m;P<0.001)。有趣的是,在功能较差的患者中,六分钟和递增式往返步行试验的步行距离差异更大。两次试验内差异的平均偏差±95%CI 相似(分别为 7±40 m 和 8±45 m)。峰值 VO₂与生存率相关,但两项试验中的步行距离均与生存率无关(P<0.05)。
在 CHF 患者中,递增式往返步行试验在估计峰值 VO₂方面显示出与六分钟步行试验相似的重复性和准确性。然而,直接测量峰值 VO₂在预测生存率方面仍然优于任何一种步行试验——至少在功能能力保存良好的患者中如此。